We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+11.15%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$8.8B
AUM Growth
-$819M
Cap. Flow
-$1.75B
Cap. Flow %
-19.89%
Top 10 Hldgs %
37.49%
Holding
1,086
New
112
Increased
123
Reduced
630
Closed
126

Sector Composition

Rank Sector Weight
1 Technology 28.43%
2 Financials 19.76%
3 Healthcare 14.3%
4 Real Estate 8.12%
5 Industrials 6.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLN icon
701
Haleon
HLN
$44.2B
$1.12M 0.01%
+183,814
New +$1.19M
EPR icon
702
EPR Properties
EPR
$4.77B
$1.11M 0.01%
30,989
-10,810
-26% -$510K
COVA
703
DELISTED
COVA Acquisition Corp. Class A Ordinary Share
COVA
$1.1M 0.01%
110,863
-11,098
-9% -$110K
ORIC icon
704
Oric Pharmaceuticals
ORIC
$1.4B
$1.1M 0.01%
343,002
-18,053
-5% -$72.3K
ITOS
705
DELISTED
iTeos Therapeutics
ITOS
$1.09M 0.01%
57,500
+5,000
+10% +$115K
KR icon
706
Kroger
KR
$34.8B
$1.09M 0.01%
+25,000
New +$1.19M
EWTX icon
707
Edgewise Therapeutics
EWTX
$4.68B
$1.09M 0.01%
110,750
-14,250
-11% -$144K
BBBY
708
PUT
DELISTED
Bed Bath & Beyond Inc
BBBY
$1.09M 0.01%
325,700
+91,500
+39% +$745K
LEN.B icon
709
Lennar Class B
LEN.B
$20.8B
$1.09M 0.01%
19,196
-492
-2% -$29.9K
JLL icon
710
Jones Lang LaSalle
JLL
$16.7B
$1.06M 0.01%
7,024
-181
-3% -$31.5K
TARS icon
711
Tarsus Pharmaceuticals
TARS
$2.84B
$1.04M 0.01%
+61,000
New +$969K
HLVX
712
DELISTED
HilleVax
HLVX
$1.04M 0.01%
60,943
-30,000
-33% -$436K
MORF
713
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1.03M 0.01%
36,534
-3,000
-8% -$83.6K
VTYX
714
DELISTED
Ventyx Biosciences
VTYX
$1.03M 0.01%
+29,400
New +$651K
ADPT icon
715
Adaptive Biotechnologies
ADPT
$3.97B
$1.02M 0.01%
143,490
-70,000
-33% -$659K
NRG icon
716
NRG Energy
NRG
$24.8B
$1.02M 0.01%
26,623
-18,700
-41% -$746K
RCUS icon
717
Arcus Biosciences
RCUS
$3.64B
$1.01M 0.01%
38,725
-11,700
-23% -$309K
OGE icon
718
OGE Energy
OGE
$9.71B
$1.01M 0.01%
+27,587
New +$1.11M
ESTA icon
719
Establishment Labs
ESTA
$2.28B
$979K 0.01%
17,926
-11,500
-39% -$687K
UAL icon
720
PUT
United Airlines
UAL
$42.1B
$976K 0.01%
361,200
W icon
721
Wayfair
W
$14.6B
$960K 0.01%
+29,500
New +$1.56M
NVNO
722
enVVeno Medical
NVNO
$7.08M
$940K 0.01%
4,278
+903
+27% +$192K
ASAX
723
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
$939K 0.01%
95,450
-9,555
-9% -$94.1K
RACB
724
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$937K 0.01%
95,450
-9,555
-9% -$93.8K
ROCL
725
DELISTED
Roth CH Acquisition V Co. Common Stock
ROCL
$935K 0.01%
93,581
-9,368
-9% -$92.8K

Similar funds

UBS O'Connor's Q3 2022 Portfolio in Review

As of Q3 2022, UBS O'Connor held 1,086 positions worth $8.8B, down 8.5% from $9.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

UBS O'Connor withdrew a net $1.75B in Q3 2022, closing 126 positions and reducing 630 holdings. Its most notable exit was American Campus Communities, Inc., an estimated $463M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Avalara, Inc. worth $373M.

  • UBS O'Connor's largest Q3 2022 buy was Avalara, Inc.: 4,065,318 shares worth $373M.
  • UBS O'Connor added most to ZENDESK INC in Q3 2022, an estimated $355M increase.
  • UBS O'Connor's biggest Q3 2022 reduction was TSMC, cutting an estimated $77.7M.
  • UBS O'Connor fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $463M.
  • UBS O'Connor's ten largest holdings make up 37% of its $8.8B portfolio in Q3 2022.
  • UBS O'Connor opened 112 new positions and closed 126 in Q3 2022.
  • UBS O'Connor's portfolio value fell 8.5% quarter-over-quarter to $8.8B.

Based on UBS O'Connor's 13F filing for Q3 2022, filed 14 Nov 2022.